Carmela Parenti Selected Research

Hyperalgesia

1/2021	The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling.
5/2020	Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists.
4/2020	Lipid Nanoparticle Inclusion Prevents Capsaicin-Induced TRPV1 Defunctionalization.
11/2019	Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain.
6/2016	Harpagophytum procumbens extract potentiates morphine antinociception in neuropathic rats.
9/2015	Involvement of the Heme-Oxygenase Pathway in the Antiallodynic and Antihyperalgesic Activity of Harpagophytum procumbens in Rats.
3/2014	The antagonistic effect of the sigma 1 receptor ligand (+)-MR200 on persistent pain induced by inflammation.
2/2014	Effects of a selective sigma 1 antagonist compound on inflammatory pain.
8/2013	The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures.
4/2012	Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carmela Parenti Research Topics

Disease

19	Pain (Aches) 07/2021 - 07/2007
11	Hyperalgesia 01/2021 - 07/2009
8	Chronic Pain 04/2020 - 07/2009
6	Neuralgia (Stump Neuralgia) 05/2022 - 08/2013
5	Inflammation (Inflammations) 07/2017 - 07/2009
4	Neoplasms (Cancer) 07/2019 - 01/2015
3	Neuroblastoma 01/2019 - 01/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2021 - 01/2014
2	Neuroinflammatory Diseases 01/2021 - 01/2019
2	Edema (Dropsy) 03/2014 - 02/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2017
1	Lung Injury 07/2017
1	Wilms Tumor (Wilm's Tumor) 05/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	Glioma (Gliomas) 01/2015
1	Neurofibrosarcoma (MPNST) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 05/2011

Drug/Important Bio-Agent (IBA)

11	LigandsIBA 07/2021 - 05/2011
9	Opioid Analgesics (Opioids)IBA 07/2021 - 04/2012
6	Pharmaceutical PreparationsIBA 07/2021 - 01/2016
6	CarrageenanIBA 09/2015 - 07/2009
5	Opioid Receptors (Opioid Receptor)IBA 05/2022 - 06/2012
5	Biological ProductsIBA 01/2016 - 07/2007
4	Analgesics (Analgesic Drugs)IBA 07/2019 - 01/2012
3	Connexin 43 (Connexin43)IBA 02/2021 - 10/2017
3	NociceptinIBA 01/2012 - 07/2007
2	CytokinesIBA 05/2022 - 01/2021
2	delta Opioid Receptors (delta Opioid Receptor)IBA 05/2022 - 11/2019
2	ConnexinsIBA 05/2022 - 02/2021
2	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2019 - 01/2012
2	BenzomorphansIBA 11/2019 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2012
2	ProdrugsIBA 10/2017 - 01/2015
2	Haloperidol (Haldol)FDA LinkGeneric 10/2017 - 01/2015
2	Morphine (MS Contin)FDA LinkGeneric 06/2016 - 01/2012
1	Interleukin-6 (Interleukin 6)IBA 05/2022
1	Ion Channels (Ion Channel)IBA 09/2020
1	Lipid NanoparticlesIBA 04/2020
1	Antidepressive Agents (Antidepressants)IBA 07/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2019
1	Serotonin (5 Hydroxytryptamine)IBA 07/2019
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 07/2019
1	Formaldehyde (Formol)FDA Link 03/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	normetazocineIBA 03/2018
1	Naloxone (Narcan)FDA LinkGeneric 03/2018
1	Conditioned Culture MediaIBA 10/2017
1	Neuroprotective AgentsIBA 10/2017
1	Heme Oxygenase-1IBA 07/2017
1	Oxygen (Dioxygen)IBA 07/2017
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 07/2017
1	AntioxidantsIBA 07/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2017
1	Transcription Factors (Transcription Factor)IBA 05/2015
1	WT1 ProteinsIBA 05/2015
1	Artificial Membranes (Artificial Membrane)IBA 01/2015
1	Histone Deacetylase InhibitorsIBA 11/2014
1	1- (3',4'- dichloro- 2- fluoro(1,1'- biphenyl)- 4- yl)cyclopropanecarboxylic acidIBA 01/2014
1	Substance PIBA 04/2012
1	NeuropeptidesIBA 04/2012
1	J 113397IBA 01/2012
1	nocistatinIBA 01/2012
1	(Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)IBA 07/2009

Therapy/Procedure

2	Ligation 01/2021 - 11/2019
2	Analgesia 01/2019 - 04/2012
2	Therapeutics 07/2017 - 01/2015
1	Denervation 04/2020
1	Injections 01/2012